시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
원료의약품 시장 규모, 점유율, 성장 분석 : 분자별, 유형별, 제조업체별, 화학 합성별, 치료 용도별, 지역별 - 산업 예측(2025-2032년)
Active Pharmaceutical Ingredients Market Size, Share, and Growth Analysis, By Molecule, By Type, By Type of Manufacturer, By Synthesis, By Chemical Synthesis, By Therapeutic Application, By Region - Industry Forecast 2025-2032
상품코드 : 1687490
리서치사 : SkyQuest
발행일 : 2025년 03월
페이지 정보 : 영문 248 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,590,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 8,879,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,168,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

세계의 원료의약품(API) 시장 규모는 2023년에 2,230억 달러로 평가되며, 2024년 2,383억 9,000만 달러에서 2032년에는 4,065억 4,000만 달러로 성장하며, 예측 기간 중(2025-2032년) CAGR은 6.9%로 성장할 전망입니다.

세계 원료의약품(API) 시장은 만성질환률 증가, 제네릭 의약품 수요 증가, 연구개발 활동의 활성화로 인해 진화하고 있습니다. 특히 생명공학 기술을 활용한 제조 공정의 기술 발전이 시장 성장에 박차를 가하고 있습니다. 품질과 안전성을 최우선으로 하는 수탁제조기관(CMO)에 의한 원료의약품 제조 아웃소싱이 두드러진 추세로, 제약기업은 복잡한 규제를 극복하고 핵심 역량에 집중할 수 있습니다. 중국과 인도는 비용 효율성과 탄탄한 제약 인프라를 바탕으로 원료의약품 제조의 주요 기업으로 부상하고 있습니다. API는 단회 투여 및 복합제 모두에 필수적이며, 특히 종양학 및 순환기학을 포함한 다양한 분야의 치료 효과를 목표로 하는 API의 혁신은 보다 지속가능한 헬스케어를 약속합니다.

목차

서론

조사 방법

개요

시장 역학과 전망

주요 시장 인사이트

세계의 원료의약품(API) 시장 규모 : 분자별

세계의 원료의약품(API) 시장 규모 : 유형별

세계의 원료의약품(API) 시장 규모 : 제조업체별

세계의 원료의약품(API) 시장 규모 : 합성별

세계의 원료의약품(API) 시장 규모 : 화학 합성별

세계 원료의약품(API) 시장 규모 : 의약품의 유형별

세계의 원료의약품(API) 시장 규모 : 용도별

세계 원료의약품(API) 시장 규모 : 효력별

세계의 원료의약품(API) 시장 규모 : 치료 용도별

세계의 원료의약품(API) 시장 규모

경쟁 정보

주요 기업 개요

결론과 제안

KSA
영문 목차

영문목차

Global Active Pharmaceutical Ingredients (API) Market size was valued at USD 223.0 billion in 2023 and is poised to grow from USD 238.39 billion in 2024 to USD 406.54 billion by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).

The global Active Pharmaceutical Ingredient (API) market is evolving due to rising chronic illness rates, increased demand for generics, and intensified R&D activities. Technological advancements, particularly in biotechnological manufacturing processes, are fueling market growth. There is a notable trend toward outsourcing API production, with Contract Manufacturing Organizations (CMOs) prioritizing quality and safety, allowing pharmaceutical firms to concentrate on core competencies while navigating complex regulations. China and India have emerged as key players in API manufacturing, driven by cost-efficiency and robust pharmaceutical infrastructure. Regulatory reforms are also facilitating smoother approval processes. APIs are integral to both single-dose and fixed-dose medications, specifically targeting therapeutic effects across various fields, including oncology and cardiology. Innovations in APIs promise a more sustainable healthcare landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Active Pharmaceutical Ingredients (Api) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Active Pharmaceutical Ingredients (Api) Market Segments Analysis

Global Active Pharmaceutical Ingredients (API) Market is segmented by Molecule, Type, Type of Manufacturer, Synthesis, Chemical Synthesis, Type of Drug, Usage, Potency, Therapeutic Application and region. Based on Molecule, the market is segmented into Small Molecule and Large Molecule. Based on Type, the market is segmented into Innovative Active Pharmaceutical Ingredients and Generic Innovative Active Pharmaceutical Ingredients. Based on Type of Manufacturer, the market is segmented into Captive API Manufacturer and Merchant API Manufacturer. Based on Synthesis, the market is segmented into Synthetic Active Pharmaceutical Ingredients and Biotech Active Pharmaceutical Ingredients. Based on Chemical Synthesis, the market is segmented into Acetaminophen, Artemisinin, Saxagliptin, Sodium Chloride, Ibuprofen, Losartan Potassium, Enoxaparin Sodium, Rufinamide, Naproxen, Tamoxifen and Others. Based on Type of Drug, the market is segmented into Prescription Drugs and Over-the-Counter. Based on Usage, the market is segmented into Clinical and Research. Based on Potency, the market is segmented into Low-to-Moderate Potency Active Pharmaceutical Ingredients and Potent-to-Highly Potent Active Pharmaceutical Ingredient. Based on Therapeutic Application, the market is segmented into Cardiology, CNS and Neurology, Oncology, Orthopedic, Endocrinology, Pulmonology, Gastroenterology, Nephrology Ophthalmology and Other Therapeutic Application. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Active Pharmaceutical Ingredients (Api) Market

The Global Active Pharmaceutical Ingredients (API) market is significantly influenced by the escalating prevalence of chronic diseases and the subsequent increase in demand for therapeutic drugs, particularly as populations age and healthcare requirements become more pronounced. This has led to a heightened concentration on API development and manufacturing across diverse therapeutic sectors. Furthermore, the global emphasis on innovative cost-effective healthcare solutions, particularly within emerging markets, is bolstering drug delivery systems. Additionally, the rising consumer preference for organic products has further invigorated the API market, fostering R&D initiatives that aim to enhance the availability and effectiveness of pharmaceutical offerings.

Restraints in the Global Active Pharmaceutical Ingredients (Api) Market

A significant constraint in the Global Active Pharmaceutical Ingredients (API) market is the intricate regulatory landscape and the high levels of approval required, which can hinder growth and increase costs over time. Issues surrounding intellectual property rights and shifts in market dynamics further exacerbate these challenges. Additionally, environmental regulations impose further limitations on API production techniques, demanding the development of green chemicals that comply with eco-friendly standards. Thus, navigating these regulatory challenges is essential for sustaining growth and innovation in the API sector while addressing environmental concerns effectively.

Market Trends of the Global Active Pharmaceutical Ingredients (Api) Market

The Global Active Pharmaceutical Ingredients (API) market is witnessing a significant trend driven by the rising demand for specialty APIs tailored to unique patient populations. The biopharmaceutical sector, particularly the development of monoclonal antibodies and gene therapies, is increasingly shaping market dynamics, promoting the creation of innovative APIs. Coupled with advancements in technology, artificial intelligence, and data analytics, the efficiency and effectiveness of API development processes are improving steadily. Additionally, the growing trend of outsourcing API production to contract manufacturing organizations (CMOs) allows pharmaceutical companies to concentrate on core competencies and adapt more swiftly to market demands, enhancing overall market growth.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Active Pharmaceutical Ingredients (API) Market Size by Molecule & CAGR (2025-2032)

Global Active Pharmaceutical Ingredients (API) Market Size by Type & CAGR (2025-2032)

Global Active Pharmaceutical Ingredients (API) Market Size by Type of Manufacturer & CAGR (2025-2032)

Global Active Pharmaceutical Ingredients (API) Market Size by Synthesis & CAGR (2025-2032)

Global Active Pharmaceutical Ingredients (API) Market Size by Chemical Synthesis & CAGR (2025-2032)

Global Active Pharmaceutical Ingredients (API) Market Size by Type of Drug & CAGR (2025-2032)

Global Active Pharmaceutical Ingredients (API) Market Size by Usage & CAGR (2025-2032)

Global Active Pharmaceutical Ingredients (API) Market Size by Potency & CAGR (2025-2032)

Global Active Pharmaceutical Ingredients (API) Market Size by Therapeutic Application & CAGR (2025-2032)

Global Active Pharmaceutical Ingredients (API) Market Size & CAGR (2025-2032)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기